Home > Insider Trading > Filing (0001033905-20-000076)

Filing Details

Accession Number:: 0001033905-20-000076
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-06-05 11:38:10
Reporting Period:: 2020-06-03

Accepted Time:: 2020-06-05 11:38:10
Original Submission Date:: 2020-06-05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1033905	Luminex Corp	LMNX	Surgical & Medical Instruments & Apparatus (3841)	742747608

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1105966	Ii Walter G Loewenbaum	12212 Technology Boulevard Austin TX 78727		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-06-03	55,505	$31.02	853,910	No	4	S	Indirect	Spouse
Common Stock	Disposition	2020-06-04	44,495	$30.69	809,415	No	4	S	Indirect	Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Spouse
No	4	S	Indirect	Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	550,189	Direct
Common Stock	96,614	Indirect	Partnership
Common Stock	428,520	Indirect	Trusts

Footnotes

Date changed from 06/04/2020 as reported on original Form 4, to 06/03/2020 per market transaction date
This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1, adopted by the seller on May 27,2020 for shares acquired as founder's stock prior to the IPO on March 30, 2000. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.685 to $31.245 inclusive. Mr. Loewenbaum undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Date changed from 06/05/2020 as reported on original Form 4, to 06/04/2020 per market transaction date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.32 to $31.075 inclusive. Mr. Loewenbaum undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.